Out-of-pocket cost by cancer stage at diagnosis in commercially insured patients in the United States
CONCLUSION: Cumulative mean OOP costs among commercially insured patients during the 3-year period post-cancer diagnosis were substantial and generally higher among those with later stage cancer diagnoses. Diagnosis of cancer at earlier stages may allow for more timely treatment and lessen patient OOP costs.PMID:37907436 | DOI:10.1080/13696998.2023.2254649 (Source: Journal of Medical Economics)
Source: Journal of Medical Economics - November 1, 2023 Category: Health Management Authors: November McGarvey Matthew Gitlin Ela Fadli Karen C Chung Source Type: research
How AI is advancing asthma management? insights into economic and clinical aspects
J Med Econ. 2023 Oct 30:1-9. doi: 10.1080/13696998.2023.2277072. Online ahead of print.NO ABSTRACTPMID:37902681 | DOI:10.1080/13696998.2023.2277072 (Source: Journal of Medical Economics)
Source: Journal of Medical Economics - October 30, 2023 Category: Health Management Authors: Ahmad Z Al Meslamani Source Type: research
Cardiovascular outcomes by time-varying New York Heart Association class among patients with obstructive hypertrophic cardiomyopathy: A retrospective cohort study
CONCLUSIONS: Worsening NYHA class was associated with increased risks of all-cause mortality and CV outcomes in obstructive HCM.PMID:37902966 | DOI:10.1080/13696998.2023.2277076 (Source: Journal of Medical Economics)
Source: Journal of Medical Economics - October 30, 2023 Category: Health Management Authors: Yan Wang Weihua Gao Xu Han Jenny Jiang Belinda Sandler Xiaoyan Li Carla Zema Source Type: research
How AI is advancing asthma management? insights into economic and clinical aspects
J Med Econ. 2023 Oct 30:1-9. doi: 10.1080/13696998.2023.2277072. Online ahead of print.NO ABSTRACTPMID:37902681 | DOI:10.1080/13696998.2023.2277072 (Source: Journal of Medical Economics)
Source: Journal of Medical Economics - October 30, 2023 Category: Health Management Authors: Ahmad Z Al Meslamani Source Type: research
Cardiovascular outcomes by time-varying New York Heart Association class among patients with obstructive hypertrophic cardiomyopathy: A retrospective cohort study
CONCLUSIONS: Worsening NYHA class was associated with increased risks of all-cause mortality and CV outcomes in obstructive HCM.PMID:37902966 | DOI:10.1080/13696998.2023.2277076 (Source: Journal of Medical Economics)
Source: Journal of Medical Economics - October 30, 2023 Category: Health Management Authors: Yan Wang Weihua Gao Xu Han Jenny Jiang Belinda Sandler Xiaoyan Li Carla Zema Source Type: research
Correction
J Med Econ. 2023 Jan-Dec;26(1):1356. doi: 10.1080/13696998.2023.2275924. Epub 2023 Oct 28.NO ABSTRACTPMID:37897715 | DOI:10.1080/13696998.2023.2275924 (Source: Journal of Medical Economics)
Source: Journal of Medical Economics - October 28, 2023 Category: Health Management Source Type: research
The economic impact of obesity in Kuwait: a micro-costing study evaluating the burden of obesity-related comorbidities
CONCLUSIONS: Our study confirms that ORCs generate a significant financial burden to the public payer. The study provides an economic case for policymakers to recognize the exigency for obesity prevention and control in accordance with the ORC prevalence, and the need for sustainable investments towards body-mass index management to prevent individuals from developing multiple comorbidities.PMID:37853705 | DOI:10.1080/13696998.2023.2265721 (Source: Journal of Medical Economics)
Source: Journal of Medical Economics - October 19, 2023 Category: Health Management Authors: Salman Al-Sabah Amr ElShamy Sharanya Jois Kaywei Low Adrien Gras Ece Parali Gulnar Source Type: research
Economic burden of advanced lung cancer patients treated by gefitinib alone and combined with chemotherapy in two regions of China
CONCLUSIONS: The economic burden of lung cancer treatment mainly came from the cost of the drugs. Patients taking chemotherapy had significantly higher cost compared to patients using targeted therapy. The cost was generally higher for those with higher educational level, those with higher family income, and those living in an economically more developed city. Patients with NSCLC had higher cost compared to patients with SCLC.PMID:37855437 | DOI:10.1080/13696998.2023.2272536 (Source: Journal of Medical Economics)
Source: Journal of Medical Economics - October 19, 2023 Category: Health Management Authors: Kehong Yang Susan Hua Wenting Wei Congyan Yang Xinhai Zhu Shu Chuen Li Source Type: research
The economic impact of obesity in Kuwait: A micro-costing study evaluating the burden of obesity-related comorbidities
ConclusionsOur study confirms that ORCs generate significant financial burden to the public payer. The study provides an economic case for policymakers to recognize the exigency for obesity prevention and control in accordance with the ORC prevalence, and the need for sustainable investments towards body-mass index management to prevent individuals from developing multiple comorbidities.PMID:37853705 | DOI:10.1080/13696998.2023.2265721 (Source: Journal of Medical Economics)
Source: Journal of Medical Economics - October 19, 2023 Category: Health Management Authors: None Salman Al-Sabah Amr ElShamy Sharanya Jois Kaywei Low Adrien Gras Ece Parali Gulnar Source Type: research
Economic burden of advanced lung cancer patients treated by gefitinib alone and combined with chemotherapy in two regions of China
CONCLUSIONS: The economic burden of lung cancer treatment mainly came from the cost of the drugs. Patients taking chemotherapy had significantly higher cost compared to patients using targeted therapy. The cost was generally higher for those with higher educational level, those with higher family income, and those living in an economically more developed city. Patients with NSCLC had higher cost compared to patients with SCLC.PMID:37855437 | DOI:10.1080/13696998.2023.2272536 (Source: Journal of Medical Economics)
Source: Journal of Medical Economics - October 19, 2023 Category: Health Management Authors: Kehong Yang Susan Hua Wenting Wei Congyan Yang Xinhai Zhu Shu Chuen Li Source Type: research
The economic impact of obesity in Kuwait: A micro-costing study evaluating the burden of obesity-related comorbidities
ConclusionsOur study confirms that ORCs generate significant financial burden to the public payer. The study provides an economic case for policymakers to recognize the exigency for obesity prevention and control in accordance with the ORC prevalence, and the need for sustainable investments towards body-mass index management to prevent individuals from developing multiple comorbidities.PMID:37853705 | DOI:10.1080/13696998.2023.2265721 (Source: Journal of Medical Economics)
Source: Journal of Medical Economics - October 19, 2023 Category: Health Management Authors: None Salman Al-Sabah Amr ElShamy Sharanya Jois Kaywei Low Adrien Gras Ece Parali Gulnar Source Type: research
